| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.899 | 0.002 | 0.899 | Calcium channel blocker | 0.756 0.003 DBMET01964 0.799 0.003 DBMET01963 | ||
| 0.876 | 0.001 | 0.876 | Calcium antagonist | 0.508 0.002 DBMET01964 0.794 0.001 DBMET01963 | ||
| 0.859 | 0.003 | 0.863 | Vasodilator, coronary | 0.471 0.02 DBMET01964 0.863 0.003 DBMET01963 | DBMET01963 | |
| 0.854 | 0.003 | 0.87 | Vasodilator, peripheral | 0.64 0.012 DBMET01964 0.87 0.003 DBMET01963 | DBMET01963 | |
| 0.75 | 0.003 | 0.75 | Calcium channel (voltage-sensitive) blocker | 0.518 0.004 DBMET01964 0.473 0.004 DBMET01963 | ||
| 0.706 | 0.002 | 0.706 | Calcium channel L-type blocker | 0.491 0.002 DBMET01964 0.591 0.002 DBMET01963 | ||
| 0.663 | 0.003 | 0.683 | Calcium channel L-type activator | 0.657 0.004 DBMET01964 0.683 0.003 DBMET01963 | DBMET01963 | |
| 0.632 | 0.005 | 0.67 | Vasodilator | 0.372 0.028 DBMET01964 0.67 0.005 DBMET01963 | DBMET01963 | |
| 0.614 | 0.002 | 0.7 | Calcium channel activator | 0.529 0.004 DBMET01964 0.7 0.001 DBMET01963 | DBMET01963 | |
| 0.475 | 0.018 | 0.493 | Cardiotonic | 0.267 0.071 DBMET01964 0.493 0.016 DBMET01963 | DBMET01963 | |
| 0.478 | 0.026 | 0.488 | Spasmolytic | 0.199 0.121 DBMET01964 0.488 0.025 DBMET01963 | DBMET01963 | |
| 0.359 | 0.02 | 0.359 | P-glycoprotein inhibitor | 0.311 0.027 DBMET01964 0.353 0.021 DBMET01963 | ||
| 0.3 | 0.005 | 0.3 | TRPA1 agonist | 0.117 0.062 DBMET01964 0.218 0.008 DBMET01963 | ||
| 0.322 | 0.035 | 0.341 | Sigma receptor agonist | 0.341 0.032 DBMET01964 0.158 0.08 DBMET01963 | DBMET01964 | |
| 0.295 | 0.044 | 0.339 | Cyclic AMP phosphodiesterase inhibitor | 0.339 0.028 DBMET01963 | DBMET01963 | |
| 0.258 | 0.009 | 0.258 | Alpha 2c adrenoreceptor antagonist | 0.155 0.03 DBMET01964 0.187 0.021 DBMET01963 | ||
| 0.242 | 0.009 | 0.242 | Neuropeptide Y1 antagonist | 0.194 0.021 DBMET01964 0.242 0.009 DBMET01963 | ||
| 0.276 | 0.048 | 0.276 | 5 Hydroxytryptamine 1E antagonist | 0.19 0.143 DBMET01964 0.248 0.076 DBMET01963 | ||
| 0.273 | 0.05 | 0.334 | Psychostimulant | 0.334 0.035 DBMET01963 | DBMET01963 | |
| 0.299 | 0.088 | 0.307 | Antithrombotic | 0.307 0.083 DBMET01963 | DBMET01963 | |
| 0.228 | 0.018 | 0.255 | Alpha 2b adrenoreceptor antagonist | 0.124 0.055 DBMET01964 0.255 0.014 DBMET01963 | DBMET01963 | |
| 0.207 | 0.014 | 0.222 | Adenylate kinase inhibitor | 0.1 0.067 DBMET01964 0.222 0.012 DBMET01963 | DBMET01963 | |
| 0.227 | 0.063 | 0.259 | Platelet aggregation inhibitor | 0.259 0.048 DBMET01963 | DBMET01963 | |
| 0.218 | 0.089 | 0.282 | Platelet antagonist | 0.282 0.059 DBMET01963 | DBMET01963 | |
| 0.119 | 0.005 | 0.166 | Nicotinic alpha3beta2 receptor antagonist | 0.108 0.006 DBMET01964 0.166 0.003 DBMET01963 | DBMET01963 | |
| 0.126 | 0.028 | 0.126 | Alpha 1b adrenoreceptor antagonist | 0.087 0.041 DBMET01963 | ||
| 0.282 | 0.186 | 0.333 | Apoptosis agonist | 0.333 0.149 DBMET01964 0.283 0.185 DBMET01963 | DBMET01964 | |
| 0.116 | 0.021 | 0.143 | Glycine receptor antagonist | 0.143 0.009 DBMET01963 | DBMET01963 | |
| 0.107 | 0.014 | 0.107 | Calcium channel T-type blocker | |||
| 0.111 | 0.023 | 0.139 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 DBMET01964 0.139 0.01 DBMET01963 | DBMET01963 | |
| 0.163 | 0.088 | 0.184 | Lipocortins synthesis antagonist | 0.184 0.067 DBMET01963 | DBMET01963 | |
| 0.139 | 0.067 | 0.143 | Farnesoid X receptor antagonist | 0.143 0.061 DBMET01963 | DBMET01963 | |
| 0.131 | 0.059 | 0.396 | Anesthetic local | 0.396 0.007 DBMET01964 0.122 0.066 DBMET01963 | DBMET01964 | |
| 0.209 | 0.141 | 0.209 | Hypoxia-inducible factor 1 alpha inhibitor | 0.197 0.155 DBMET01964 0.197 0.155 DBMET01963 | ||
| 0.133 | 0.067 | 0.144 | Acetylcholinesterase inhibitor | 0.144 0.059 DBMET01964 | DBMET01964 | |
| 0.145 | 0.081 | 0.146 | Cholinergic | 0.146 0.08 DBMET01964 | DBMET01964 | |
| 0.159 | 0.1 | 0.166 | Hepatoprotectant | 0.166 0.094 DBMET01963 | DBMET01963 | |
| 0.075 | 0.019 | 0.104 | Dopamine transporter inhibitor | 0.046 0.036 DBMET01964 0.104 0.011 DBMET01963 | DBMET01963 | |
| 0.108 | 0.058 | 0.123 | Toll-Like receptor 4 antagonist | 0.114 0.05 DBMET01964 0.123 0.041 DBMET01963 | DBMET01963 | |
| 0.065 | 0.017 | 0.076 | Mineralocorticoid receptor antagonist | 0.076 0.013 DBMET01963 | DBMET01963 | |
| 0.065 | 0.017 | 0.089 | Aldosterone antagonist | 0.089 0.009 DBMET01963 | DBMET01963 | |
| 0.078 | 0.031 | 0.078 | Alpha 1d adrenoreceptor antagonist | 0.058 0.043 DBMET01963 | ||
| 0.132 | 0.093 | 0.132 | Pregnane X receptor agonist | |||
| 0.083 | 0.046 | 0.107 | Alpha 2a adrenoreceptor antagonist | 0.107 0.033 DBMET01963 | DBMET01963 | |
| 0.08 | 0.045 | 0.08 | Alpha 1a adrenoreceptor antagonist | |||
| 0.067 | 0.033 | 0.094 | Dopamine uptake inhibitor | 0.094 0.02 DBMET01963 | DBMET01963 | |
| 0.136 | 0.104 | 0.186 | CF transmembrane conductance regulator agonist | 0.186 0.031 DBMET01963 | DBMET01963 | |
| 0.129 | 0.099 | 0.131 | NOS3 expression enhancer | 0.131 0.097 DBMET01964 0.126 0.105 DBMET01963 | DBMET01964 | |
| 0.067 | 0.038 | 0.073 | Nitric oxide donor | 0.073 0.029 DBMET01963 | DBMET01963 | |
| 0.075 | 0.049 | 0.075 | Histone deacetylase stimulant | |||
| 0.075 | 0.049 | 0.075 | Histone deacetylase SIRT1 stimulant | |||
| 0.062 | 0.038 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.083 | 0.062 | 0.083 | Alpha 2 adrenoreceptor antagonist | 0.081 0.064 DBMET01963 | ||
| 0.048 | 0.027 | 0.063 | Nicotinic receptor alpha3 subunit antagonist | 0.063 0.018 DBMET01963 | DBMET01963 | |
| 0.08 | 0.065 | 0.107 | Androgen antagonist | 0.107 0.042 DBMET01963 | DBMET01963 | |
| 0.09 | 0.075 | 0.102 | Bile acid receptor antagonist | 0.102 0.045 DBMET01963 | DBMET01963 | |
| 0.102 | 0.088 | 0.136 | Acetylcholine muscarinic antagonist | 0.136 0.053 DBMET01964 | DBMET01964 | |
| 0.083 | 0.069 | 0.083 | Alpha adrenoreceptor antagonist | |||
| 0.102 | 0.09 | 0.133 | Acetylcholine antagonist | 0.133 0.06 DBMET01964 | DBMET01964 | |
| 0.12 | 0.109 | 0.146 | Acetylcholine M1 receptor antagonist | 0.146 0.079 DBMET01964 | DBMET01964 | |
| 0.102 | 0.093 | 0.137 | Cholinergic antagonist | 0.137 0.06 DBMET01964 | DBMET01964 | |
| 0.067 | 0.061 | 0.067 | Alpha 1 adrenoreceptor antagonist | |||
| 0.032 | 0.026 | 0.037 | Protein kinase C beta I inhibitor | 0.032 0.027 DBMET01964 0.037 0.014 DBMET01963 | DBMET01963 | |
| 0.032 | 0.026 | 0.037 | Transforming growth factor beta 2 antagonist | 0.037 0.016 DBMET01963 | DBMET01963 | |
| 0.078 | 0.073 | 0.078 | Antiadrenergic | |||
| 0.06 | 0.059 | 0.092 | Calcium channel P-type blocker | 0.092 0.008 DBMET01964 | DBMET01964 | |
| 0.051 | 0.055 | 0.056 | Acetyl-CoA transferase 2 inhibitor | 0.056 0.041 DBMET01963 | DBMET01963 | |
| 0.209 | 0.214 | 0.284 | Alpha-glucosidase inhibitor | 0.284 0.168 DBMET01964 | DBMET01964 | |
| 0.045 | 0.053 | 0.082 | Protein kinase C eta inhibitor | 0.054 0.039 DBMET01964 0.082 0.023 DBMET01963 | DBMET01963 | |
| 0.134 | 0.142 | 0.161 | Non-steroidal antiinflammatory agent | 0.154 0.11 DBMET01964 0.161 0.103 DBMET01963 | DBMET01963 | |
| 0.127 | 0.136 | 0.246 | Platelet adhesion inhibitor | 0.246 0.051 DBMET01964 | DBMET01964 | |
| 0.048 | 0.058 | 0.074 | Acetylcholine M2 receptor antagonist | 0.074 0.033 DBMET01964 | DBMET01964 | |
| 0.179 | 0.191 | 0.259 | Transcription factor NF kappa B inhibitor | 0.259 0.121 DBMET01963 | DBMET01963 | |
| 0.075 | 0.089 | 0.151 | Breast cancer-resistant protein inhibitor | 0.151 0.023 DBMET01964 | DBMET01964 | |
| 0.088 | 0.102 | 0.113 | Multidrug resistance-associated protein 1 inhibitor | 0.113 0.057 DBMET01964 | DBMET01964 | |
| 0.027 | 0.047 | 0.031 | ADAM10 endopeptidase inhibitor | 0.031 0.028 DBMET01963 | DBMET01963 | |
| 0.026 | 0.049 | 0.033 | Protein kinase C beta II inhibitor | 0.033 0.02 DBMET01963 | DBMET01963 | |
| 0.049 | 0.08 | 0.078 | Bcl2 antagonist | 0.078 0.034 DBMET01964 | DBMET01964 | |
| 0.039 | 0.071 | 0.061 | Nicotinic receptor alpha4 subunit antagonist | 0.061 0.021 DBMET01963 | DBMET01963 | |
| 0.058 | 0.092 | 0.101 | Acetylcholine nicotinic antagonist | 0.101 0.039 DBMET01963 | DBMET01963 | |
| 0.043 | 0.077 | 0.084 | Adrenaline uptake inhibitor | 0.084 0.025 DBMET01963 | DBMET01963 | |
| 0.039 | 0.077 | 0.054 | Acetylcholine M3 receptor antagonist | 0.054 0.05 DBMET01964 | DBMET01964 | |
| 0.057 | 0.096 | 0.067 | Phosphodiesterase VIII inhibitor | 0.067 0.06 DBMET01964 | DBMET01964 | |
| 0.113 | 0.16 | 0.148 | Anesthetic general | 0.148 0.115 DBMET01964 0.134 0.132 DBMET01963 | DBMET01964 | |
| 0.176 | 0.223 | 0.209 | Sodium/bile acid cotransporter inhibitor | 0.209 0.176 DBMET01964 | DBMET01964 | |
| 0.027 | 0.085 | 0.048 | Phenylethanolamine N methyltransferase inhibitor | 0.048 0.017 DBMET01963 | DBMET01963 | |
| 0.045 | 0.114 | 0.059 | Ryanodine receptor antagonist | 0.059 0.042 DBMET01963 | DBMET01963 | |
| 0.037 | 0.11 | 0.07 | Neuronal nicotinic receptor antagonist | 0.07 0.045 DBMET01963 | DBMET01963 | |
| 0.044 | 0.121 | 0.06 | Interferon inducer | 0.06 0.053 DBMET01964 | DBMET01964 | |
| 0.068 | 0.147 | 0.094 | Beta glucuronidase inhibitor | 0.094 0.081 DBMET01963 | DBMET01963 | |
| 0.079 | 0.165 | 0.135 | Toll-Like receptor antagonist | 0.135 0.067 DBMET01964 | DBMET01964 | |
| 0.079 | 0.167 | 0.122 | Interleukin 4 antagonist | 0.122 0.082 DBMET01964 | DBMET01964 | |
| 0.05 | 0.149 | 0.086 | Viral attachment inhibitor | 0.086 0.038 DBMET01964 | DBMET01964 | |
| 0.07 | 0.189 | 0.14 | Cytidine deaminase inhibitor | 0.14 0.083 DBMET01964 | DBMET01964 | |
| 0.029 | 0.183 | 0.06 | Beta adrenoreceptor antagonist | 0.06 0.055 DBMET01963 | DBMET01963 | |
| 0.012 | 0.195 | 0.031 | Angiotensin II receptor antagonist | 0.031 0.03 DBMET01964 | DBMET01964 | |
| 0.098 | 0.309 | 0.174 | Catenin beta inhibitor | 0.174 0.06 DBMET01963 | DBMET01963 | |
| 0.106 | 0.326 | 0.21 | Immunosuppressant | 0.21 0.186 DBMET01964 | DBMET01964 | |
| 0.139 | 0.442 | 0.275 | Caspase 9 stimulant | 0.275 0.222 DBMET01964 | DBMET01964 | |
| 0.06 | 0.394 | 0.169 | DNA damaging | 0.169 0.147 DBMET01964 | DBMET01964 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |